Date :
Place : United Kingdom, London
Contact Person:Paula Edwards
Description:
DESCRIPTION 2nd Data Integrity & Protection for Clinical Research Summit Data Integrity continues to be a primary goal of clinical research conducted by life science companies. Data can come in an organization in many avenues and is important that any data that is generated for any clinical trial needs to be valid, sufficient and of the highest quality. Procedures and processes have been implemented to advance data integrity to make successful outcomes in clinical trials. Learn from your clinical research professionals who will provide an overview of data integrity strategies, benefits, and challenges. The 2nd Data Integrity & Protection for Clinical Research SummitDeadline for abstracts/proposals : 6th December 2017
Organized By :New York Events List
Keynote Speakers : Faculty Angel Amaya Senior Clinical Research Associate, NOVARTIS Kristen Bolt Former Programme Manager, Data Sharing and Transparency, MULTI-REGIONAL CLINICAL TRIALS CENTRE OF BRIGHAM AND WOMEN’S HOSPITAL AND HARVARD Bhaswat Chakraborty Senior VP and Chair, Research and Development, CADILA PHARMACEUTICALS Sigrid Guhr GMP QA Qualification and Validation, ABBVIE Oliver Herrmann Member of the D.I.G.I.T. Committee, RESEARCH QUALITY ASSOCIATION (RQA) PHARMACEUTICALS
Conference Highlights :Top Five Reasons to Attend 1.Hear from pharmaceutical companies that found solutions and successfully ensured data integrity in clinical trials 2.Master data integrity metrics, bench marketing, and implementations to ensure data integrity in clinical trials 3.Review MHRA, FDA, and EMA inspection findings 4.Understand regulatory guidances and relationships with data quality and data integrity 5.Discuss the management of data quality using a risk-based approach to detect risks
Venue :Holland Park Avenue, London W11 4UL, United Kingdom
Check the event website for more details.